Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Genelux Stock Price, Quotes and Forecasts | NASDAQ:GNLX | Benzinga
Explore Genelux stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GNLX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Genelux (GNLX) stock?
You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.
Who are Genelux (GNLX) competitors?
Other companies in Genelux’s space includes: Macrogenics (NASDAQ:MGNX), Renovaro (NASDAQ:RENB), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP) and RAPT Therapeutics (NASDAQ:RAPT).
What is the forecast, or price target, for Genelux (GNLX) stock?
Genelux has a consensus price target of $23.00.
What is the current price for Genelux (GNLX)?
The stock price for Genelux (NASDAQ: GNLX) is $4.2 last updated February 28, 2025 at 2:39 PM EST.
Does Genelux (GNLX) pay a dividend?
There are no upcoming dividends for Genelux.
When is Genelux (NASDAQ:GNLX) reporting earnings?
Genelux’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Genelux (GNLX) going to split?
There is no upcoming split for Genelux.
What sector and industry does Genelux (GNLX) operate in?
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.